Revier Therapeutics: Funding, Investors & Team (Oct 2026)
Revier Therapeutics develops small-molecule therapies for cardiometabolic diseases.
Revier Therapeutics has raised $7.0M across 1 funding round on record, the most recent a Seed of $7.0M announced in Aug 2026.
That round is above the $3.2M median round size for Belgium companies tracked on FundedIQ over the last two years.
Revier Therapeutics Company Profile and Key Stats
Latest funding round on record: Aug 2026.
Revier Therapeutics Funding Rounds
Revier Therapeutics Investors
Revier Therapeutics Funding in Context
Revier Therapeutics' latest round of $7.0M is above the median round in Belgium. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Revier Therapeutics in Biotechnology and Deidenberg
Companies Similar to Revier Therapeutics
NOX Energy builds smart energy software connecting homes to power markets, cutting costs and boosting grid…
Turning biomass residues into fit-for-purpose microbial fertilizers, biostimulants and biocontrols.
Spotable is an AI software for exterior contractors, automating roofing, facade, and industrial measurements.
A biopharmaceutical business called Novadip Biosciences was established with the goal of creating,…
Tusk IC offers IC design services in the latest CMOS and SiGe processes, from feasibility study, design, to…
Chift simplifies the process of integrating software for companies. By connecting to Chift, multiple native…
Backbone integrates your quality data, surfaces the relevant signals at the right moment, and empowers…
Amyl therapeutics is a preclinical-stage biotechnology company pioneering a breakthrough approach to treating…
Motion is an OEM-agnostic Humanoids-as-a-Service (HaaS) platform operator that accelerates the commercial…
MAASH is a biotech mycoprotein producing company that supply a nutritious and health feed and food protein…
Sol.One is a hardwae company that offers flight control, battery MGMT, ground station, comms, and logging…
Revier Therapeutics Funding FAQs
What does Revier Therapeutics do?
Revier Therapeutics develops small-molecule therapies for cardiometabolic diseases.
How much funding has Revier Therapeutics raised?
Revier Therapeutics has raised $7.0M across 1 round on record. The most recent is a Seed of $7.0M announced in Aug 2026.
When did Revier Therapeutics last raise funding?
Revier Therapeutics' most recent funding round on record is a Seed of $7.0M, announced in Aug 2026.
Who has invested in Revier Therapeutics?
Investors on record for Revier Therapeutics include HTGF (High-Tech Gruenderfonds), KHAN Technology Transfer Fund, VORNvc.
Where is Revier Therapeutics headquartered?
Revier Therapeutics is based in Deidenberg, Belgium.
How many employees does Revier Therapeutics have?
Revier Therapeutics is in the 1-10 employee band.
When was Revier Therapeutics founded?
Revier Therapeutics was founded in 2023.
About FundedIQ's Revier Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Revier Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.